 Measuring swallow function in HNSCC remains a particularly challenge as efforts continue to strive towards the development of function preserving organ cancer therapy. It has arguably taken on a greater prominence in light of the changing epidemiology of OPSCC 8, 9 where an increasing number of OPSCC oropharyngeal squamous cell cancer patients have cancers associated with the human papillomavirus HPV that have a favourable prognosis regardless of whether surgical or non-surgical management approaches are undertaken 10. This changing epidemiology, which some have described in epidemic proportions 9, suggests that an increasing number of cancer survivors will be at risk of developing late complications especially those related to swallow function. While arguably this tenet remains to be firmly established, to do so highlights several challenges that are important to address. These include establishing an effective strategy to longitudinally measure swallow function that also reflects the cluster of other treatment-related symptoms that can affect swallow such as taste changes and xerostomia 6. It requires not only a valid tool but one that lends itself to repeat ease of use ideally within a patients ecologic environment to minimize bias and preferably within an infrastructure that readily curates this measure for analysis. 